External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy.
JAMA Netw Open
; 5(1): e2144170, 2022 01 04.
Article
in En
| MEDLINE
| ID: mdl-35044469
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radioisotopes
/
Severity of Illness Index
/
Receptors, Peptide
/
Neuroendocrine Tumors
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
JAMA Netw Open
Year:
2022
Document type:
Article
Country of publication:
United States